GAPDH and COVID-19: The ratio of dihydroxyacetone phosphate:1,3-bisphosphoglycerate (DHAP:BPG) increased in severe COVID-19 neutrophils, consistent with a reduction in GAPDH activity (Fig. 2a, b).